Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Michael Lachowicz"'
Autor:
Julia Blanter, Michael Werner, Melanie Wain Kier, Olivia Hapanowicz, Muhieddine Itani, Maham Ahmad, Mandy DeMerchant, Joseph Paul Eder, Matt D. Galsky, Ashley Hammad, Paula King, Michael Lachowicz, Natalie Lucas, Thomas Urban Marron, Gary Shelton, Kathy Wu, Suzanne Xu, Patricia LoRusso, Erin Wysong Hofstatter, Deborah Blythe Doroshow
Publikováno v:
Journal of Clinical Oncology. 40:267-267
267 Background: Financial toxicity (FT) adversely influences patient quality of life and is a barrier to clinical trial enrollment. Early phase clinical trials (EPTs) primarily recruit patients with advanced malignancies who have received all standar
Autor:
Michael Lachowicz, Maria Athanasiou, Anil K. Malhotra, Igor Mosyagin, John M. Kane, Stanton L. Gerson, Ingolf Cascorbi, Michael Dettling, Carol R. Reed, Brad Dain
Publikováno v:
Blood. 108:1280-1280
Clozapine is a highly efficacious drug for the treatment of schizophrenia, but its use is limited, in part due to the side effect of agranulocytosis. In order to reduce the incidence of clozapine-induced agranulocytosis (CIA), patients are required t
Autor:
Stanton L. Gerson, Michael Lachowicz, Janet Carr, Heidi Whalen, Carol R. Reed, Maria Athanasiou, John M. Kane, Bradley Dain, Anil K. Malhotra
Publikováno v:
Blood. 106:3074-3074
Clozapine is a highly efficacious drug for the treatment of schizophrenia, but its use is limited, in part due to the side effect of agranulocytosis. In order to reduce the incidence of clozapine-induced agranulocytosis (CIA), patients are required t